Evidence map›Paper›PMID 36323673›Full record

ArticleNature communications2022

HIF1α-AS1 is a DNA:DNA:RNA triplex-forming lncRNA interacting with the HUSH complex.

Matthias S Leisegang, Jasleen Kaur Bains, Sandra Seredinski, James A Oo, Nina M Krause, Chao-Chung Kuo, Stefan Günther, Nevcin Sentürk Cetin, Timothy Warwick, Can Cao and 21 more

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. RNA•DNA:DNA triplex formation byRNA (New York, N.Y.) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Biomolecular NMR assignments · 2025
    Article
  7. Review
  8. Article
  9. Unraveling LncRNAs: the future of lung cancer treatment.Journal of the Egyptian National Cancer Institute · 2025
    Review
  10. Article
  11. The relevance of RNA-DNA interactions as regulators of physiological functions.Pflugers Archiv : European journal of physiology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Matthias S Leisegang *Institute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.ORCID 0000-0002-6084-6484
Jasleen Kaur Bains *Institute for Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Goethe University, Frankfurt, Germany.ORCID 0000-0002-1062-0436
Sandra SeredinskiInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.
James A OoInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.
Nina M KrauseInstitute for Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Goethe University, Frankfurt, Germany.
Chao-Chung KuoInstitute for Computational Genomics, Joint Research Center for Computational Biomedicine, RWTH Aachen Medical Faculty, Aachen, Germany.ORCID 0000-0001-8879-4754
Stefan GüntherMax Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.ORCID 0000-0002-5594-4549
Nevcin Sentürk CetinDivision of Molecular Biology of the Cell II, German Cancer Research Center DKFZ-ZMBH, Heidelberg, Germany.
Timothy WarwickInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.ORCID 0000-0002-6804-2931
Can CaoInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.
Frederike BoosInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.ORCID 0000-0002-1842-5459
Judit Izquierdo PonceInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.
Shaza HaydarInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.
Rebecca BednarzInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.ORCID 0000-0003-2565-0459
Chanil ValasarajanMax Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Dominik C FuhrmannFaculty of Medicine, Institute of Biochemistry I, Goethe University, Frankfurt, Germany.ORCID 0000-0002-4902-9387
Jens PreussnerMax Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.ORCID 0000-0003-1927-3458
Mario LoosoMax Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.ORCID 0000-0003-1495-9530
Soni S PullamsettiMax Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.ORCID 0000-0003-0440-8831
Marcel H SchulzGerman Center of Cardiovascular Research (DZHK), Partner site RheinMain, Frankfurt, Germany.ORCID 0000-0002-1252-3656
Hendrik R A JonkerInstitute for Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Goethe University, Frankfurt, Germany.ORCID 0000-0002-5582-3931
Christian RichterInstitute for Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Goethe University, Frankfurt, Germany.
Flávia RezendeInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.
Ralf GilsbachInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.ORCID 0000-0002-0895-1535
Beatrice Pflüger-MüllerInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.
Ilka WittigInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany.ORCID 0000-0002-9751-8054
Ingrid GrummtDivision of Molecular Biology of the Cell II, German Cancer Research Center DKFZ-ZMBH, Heidelberg, Germany.
Teodora RibarskaDivision of Molecular Biology of the Cell II, German Cancer Research Center DKFZ-ZMBH, Heidelberg, Germany.
Ivan G CostaInstitute for Computational Genomics, Joint Research Center for Computational Biomedicine, RWTH Aachen Medical Faculty, Aachen, Germany.ORCID 0000-0003-2890-8697
Harald SchwalbeInstitute for Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Goethe University, Frankfurt, Germany. schwalbe@nmr.uni-frankfurt.de.ORCID 0000-0001-5693-7909
Ralf P BrandesInstitute for Cardiovascular Physiology, Goethe University, Frankfurt, Germany. brandes@vrc.uni-frankfurt.de.ORCID 0000-0002-8035-0048

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

dnaDNA:RNA triplexes that are formed through Hoogsteen base-pairing of the RNA in the major groove of the DNA duplex have been observed in vitro, but the extent to which these interactions occur in cells and how they impact cellular functions remains elusive. Using a combination of bioinformatic techniques, RNA/DNA pulldown and biophysical studies, we set out to identify functionally important DNA:DNA:RNA triplex-forming long non-coding RNAs (lncRNA) in human endothelial cells. The lncRNA HIF1α-AS1 was retrieved as a top hit. Endogenous HIF1α-AS1 reduces the expression of numerous genes, including EPH Receptor A2 and Adrenomedullin through DNA:DNA:RNA triplex formation by acting as an adapter for the repressive human silencing hub complex (HUSH). Moreover, the oxygen-sensitive HIF1α-AS1 is down-regulated in pulmonary hypertension and loss-of-function approaches not only result in gene de-repression but also enhance angiogenic capacity. As exemplified here with HIF1α-AS1, DNA:DNA:RNA triplex formation is a functionally important mechanism of trans-acting gene expression control.

Indexed as

RNA, Long NoncodingBase PairingDNAEndothelial CellsGene Expression Regulation, NeoplasticHumansOligonucleotidesDNAOligonucleotidesRNA, Long Noncoding

Identifiers

PMID36323673
PMCPMC9630315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.